Home/Filings/4/0001209191-21-004418
4//SEC Filing

Wenqing Yao 4

Accession 0001209191-21-004418

CIK 0000879169other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 5:40 PM ET

Size

8.2 KB

Accession

0001209191-21-004418

Insider Transaction Report

Form 4
Period: 2021-01-15
Wenqing Yao
Ex VP Discovery Medicinal Chem
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-01-15+12,74312,743 total
    Exercise: $90.56Exp: 2031-01-14Common Stock (12,743 underlying)
  • Award

    Common Stock

    2021-01-15+11,522143,784 total
Footnotes (4)
  • [F1]Represents award of restricted stock units ("RSUs") that will vest 100% on the fourth anniversary of the grant date of January 15, 2021, subject to Wenqing Yao's continued service with the Issuer through the applicable vesting date. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  • [F2]Including the January 15, 2020 Restricted Stock Unit Grant, this includes an aggregate of 108,222 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
  • [F3]This total excludes 24,589 shares that were erroneously reported as being owned by the reporting person in the reporting persons Form 4 filed on June 22, 2020 and three Forms 4 filed by the reporting person after that date.
  • [F4]Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001624033

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:40 PM ET
Size
8.2 KB